Effect of Pioglitazone and Ramipril on Biomarkers of Low-Grade Inflammation and Vascular Function in Nondiabetic Patients with Increased Cardiovascular Risk and an Activated Inflammation: Results from the PIOace Study

AIMS: This study investigated the effects of pioglitazone (PIO), ramipril (RAM), or their combination (PIRA) on low-grade inflammation in nondiabetic hypertensive patients with increased cardiovascular risk. METHODS AND RESULTS: Patients enrolled in this placebo-controlled, double-blind, randomized,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Pfützner, Andreas, Hanefeld, Markolf, Dekordi, Lida A, Müller, Jürgen, Kleine, Iris, Fuchs, Winfried, Forst, Thomas
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Diabetes Technology Society 2011
Gaiak:
Biomarkers of Diabetes
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3192606/
https://ncbi.nlm.nih.gov/pubmed/21880242
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak